Showing results (591-600 of 2,465) with videos related to

Sort By:
Pageof 247
Cancer Treatment Reviews|June 24, 2026
Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomesFausto Petrelli, Lorenzo Dottorini, Andrea Celotti, et al.
Cancer Treatment Reviews|June 23, 2026
Cyclotherapy: exploiting cell-cycle decoupling for selective cancer cytotoxicity and normal-tissue protectionD Izzo, R M Marsicano, D Trapani, et al.
Cancer Treatment Reviews|May 7, 2026
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitorsIrene Hernández de Córdoba Sánchez, Mercedes Avedillo Ruidiaz, Victor Moreno, et al.
Cancer Treatment Reviews|August 6, 2026
Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patientsLianne M Haveman, Lisa L Hjalgrim, Cristina Mata Fernández, et al.
Cancer Treatment Reviews|September 10, 2026
From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncologyAlena Opattova, Katie Jean Znidericz, Giulia Chiabotto, et al.
Cancer Treatment Reviews|September 2, 2026
MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axisZhaohui Liao Arter, Joo Sung Gabriel Shim, Cathleen Park, et al.
Cancer Treatment Reviews|September 16, 2026
Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trialsAna-Maria Dudău, Jean Zeghondy, George Emile, et al.
Cancer Treatment Reviews|October 3, 2026
"Current approaches and emerging strategies in the treatment of ductal carcinoma in situ and premalignant breast lesions"Tommaso Ruelle, Edoardo Chiappe, Chiara Lanzavecchia, et al.
Cancer Treatment Reviews|October 9, 2026
Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment optionsMichela Palleschi, Alessandro Viansone, Filippo Merloni, et al.
Cancer Treatment Reviews|October 13, 2026
The prognostic value of pathological response in soft tissue sarcoma: A systematic reviewBauke H G van Riet, Stijn J C van der Burg, Tom van der Klaauw, et al.
Pageof 247